ES8602716A1 - Procedimiento para la preparacion de derivados de tiazolidina. - Google Patents

Procedimiento para la preparacion de derivados de tiazolidina.

Info

Publication number
ES8602716A1
ES8602716A1 ES541705A ES541705A ES8602716A1 ES 8602716 A1 ES8602716 A1 ES 8602716A1 ES 541705 A ES541705 A ES 541705A ES 541705 A ES541705 A ES 541705A ES 8602716 A1 ES8602716 A1 ES 8602716A1
Authority
ES
Spain
Prior art keywords
preparation
thiazolidine derivatives
pharmaceutical preparations
hydrogen
intermediates therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES541705A
Other languages
English (en)
Other versions
ES541705A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES541705A0 publication Critical patent/ES541705A0/es
Publication of ES8602716A1 publication Critical patent/ES8602716A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/08Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE TIAZOLIDINA. CONSISTENTE EN NITRAR UN COMPUESTO DE FORMULA GENERAL (II), OBTENIENDOSE LOS COMPUESTOS DE FORMULA GENERAL (I), DONDE X SIGNIFICA METILENO, OXIGENO O AZUFRE; R1 SIGNIFICA HALOGENO O NITRO Y SUS SALES CON CATIONES FISIOLOGICAMENTE COMPATIBLES. APLICACION EN EL TRATAMIENTO DE DIABETES MELLITUS Y PARA LA PREVENCION DE COMPLICACIONES TALES COMO CATARATAS Y NEUROPATIAS QUE CON ELLO APARECEN.
ES541705A 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina. Expired ES8602716A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH343283 1983-06-23
CH186084 1984-04-13

Publications (2)

Publication Number Publication Date
ES541705A0 ES541705A0 (es) 1985-12-01
ES8602716A1 true ES8602716A1 (es) 1985-12-01

Family

ID=25688868

Family Applications (4)

Application Number Title Priority Date Filing Date
ES533624A Granted ES533624A0 (es) 1983-06-23 1984-06-22 Procedimiento para la preparacion de derivados de tiazolidina
ES541705A Expired ES8602716A1 (es) 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina.
ES541708A Granted ES541708A0 (es) 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina.
ES541707A Expired ES8602718A1 (es) 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES533624A Granted ES533624A0 (es) 1983-06-23 1984-06-22 Procedimiento para la preparacion de derivados de tiazolidina

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES541708A Granted ES541708A0 (es) 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina.
ES541707A Expired ES8602718A1 (es) 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina.

Country Status (11)

Country Link
US (1) US4587256A (es)
EP (1) EP0129747A3 (es)
AU (1) AU2947784A (es)
DK (1) DK277484A (es)
ES (4) ES533624A0 (es)
FI (1) FI842327A (es)
HU (1) HUT34509A (es)
IL (1) IL72139A0 (es)
MC (1) MC1601A1 (es)
NO (1) NO842515L (es)
PT (1) PT78778B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
JPH06772B2 (ja) * 1984-07-09 1994-01-05 鐘淵化学工業株式会社 3―(4―フルオロフエノキシ)プロピオニトリルを用いる6―フルオロ―4―クロマノンの製造法
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
CA2396713A1 (en) * 1999-12-22 2001-07-05 Metabasis Therapeutics, Inc. Novel bisamidate phosphonate prodrugs
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
WO2005116002A2 (en) * 2004-05-24 2005-12-08 Amgen Inc. Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
US8686011B2 (en) 2004-05-24 2014-04-01 Amgen Inc. Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
RU2007102288A (ru) * 2004-08-18 2008-09-27 Мебабазис Терапеутикс, Инк. (Us) Новые тиазольные ингибиторы фруктозо-1,6-бисфосфатазы
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
CN115322208B (zh) * 2021-05-10 2023-04-11 中国药科大学 2-氨基噻唑类衍生物及其制备方法和医药用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210756A (en) * 1976-10-18 1980-07-01 Pfizer Inc. Tetrahydroquinoline hydantoins for chronic diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines

Also Published As

Publication number Publication date
PT78778B (en) 1986-09-15
ES8602719A1 (es) 1985-12-01
HUT34509A (en) 1985-03-28
ES8602820A1 (es) 1985-12-16
ES533624A0 (es) 1985-12-16
DK277484A (da) 1984-12-24
PT78778A (en) 1984-07-01
ES541705A0 (es) 1985-12-01
FI842327A (fi) 1984-12-24
DK277484D0 (da) 1984-06-04
FI842327A0 (fi) 1984-06-08
EP0129747A2 (de) 1985-01-02
MC1601A1 (fr) 1985-05-09
ES541708A0 (es) 1985-12-01
IL72139A0 (en) 1984-10-31
US4587256A (en) 1986-05-06
ES541707A0 (es) 1985-12-01
NO842515L (no) 1984-12-27
ES8602718A1 (es) 1985-12-01
AU2947784A (en) 1985-01-03
EP0129747A3 (de) 1985-09-25

Similar Documents

Publication Publication Date Title
ES8802048A1 (es) Procedimiento para preparar derivados de imidazo(1,5-a)piridina
ES8602716A1 (es) Procedimiento para la preparacion de derivados de tiazolidina.
FI861506A (fi) Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra).
ES8503339A1 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
AU582043B2 (en) Phenoxyalkylcarboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
DK72686A (da) Aminosyrederivat og antikonvulsant praeparat som indeholder derivatet
ES8504719A1 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
DE3782207D1 (de) 2-acyloxypropylamin-derivate, verfahren zur herstellung und diese enthaltende arzneimittel.
ATE30152T1 (de) 1-methyl-5-nitro-imidazolin-derivate und diese enthaltende therapeutische zusammensetzungen.
ES464483A1 (es) Procedimiento para la obtencion de ortoaminoacetofenonas.
ES8801652A1 (es) Un procedimiento para la preparacion de un derivado de tiazolidina.
ATE48424T1 (de) Esterderivate von 2-alpha-hydroxy-substituierter 4-hydroxy-3-chinolincarbonsaeure, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ATE33837T1 (de) Azolylmethylcycloacetale, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES8602797A1 (es) Procedimiento para preparar 11-piperazinil-5h-imidazo(2, 1-c) (1, 4) benzodiazepinas
SE8501993D0 (sv) New apovincaminol derivatives, process for their preparation and pharmaceutical compositions containing them
AU579416B2 (en) 3-Amino-2,3-dihydro-1-benzoxepine-compounds and methods for their preparation and pharmaceutical preparations containing these compounds
FI842639A (fi) Acylderivat av 1,4,3,6-dianhydro- hexitol.
DE3361834D1 (en) Dithiino (1,4) (2,3-c) pyrrole derivatives, their preparation and pharmaceutical compositions containing them